Intra-Articular Drug Delivery for Osteoarthritis Treatment
Osteoarthritis (OA) is the most prevalent degenerative joint disease affecting millions of people worldwide. Currently, clinical nonsurgical treatments of OA are only limited to pain relief, anti-inflammation, and viscosupplementation. Developing disease-modifying OA drugs (DMOADs) is highly demande...
Saved in:
Main Authors: | Yifeng Cao (Author), Yifeng Ma (Author), Yi Tao (Author), Weifeng Lin (Author), Ping Wang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knee Osteoarthritis Therapy: Recent Advances in Intra-Articular Drug Delivery Systems
by: Ma L, et al.
Published: (2022) -
Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
by: Longfa Kou, et al.
Published: (2019) -
Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis
by: Xiuping Zhang, et al.
Published: (2018) -
Osteoarthritis In Vitro Models: Applications and Implications in Development of Intra-Articular Drug Delivery Systems
by: Carlota Salgado, et al.
Published: (2021) -
Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage
by: Huirong Huang, et al.
Published: (2022)